Printer Friendly

Clarity Medical Systems Launches HOLOS IntraOp Technology.

M2 PHARMA-November 16, 2015-Clarity Medical Systems Launches HOLOS IntraOp Technology


- US-based Clarity Medical Systems, Inc., a medical device company focused on the manufacture of integrated optical systems for the diagnosis and management of eye disorders, has launched its HOLOS IntraOp Intraoperative Wavefront Aberrometer, the company said.

According to Clarity, the device displays qualitative and quantitative refractive data in real time, providing immediate feedback on how surgical adjustments may affect postsurgical refraction during the many steps of cataract surgery.

Among its many features, HOLOS IntraOp offers active monitoring of sphere, cylinder, and axis measurements, and it provides live feedback to the surgeon while rotating toric IOLs, titrating limbal relaxing incisions, and opening arcuate incisions.

The HOLOS IntraOp can be used in any cataract surgery, but it was specifically designed with advanced technology IOLs in mind. HOLOS takes 90 measurements per second, with a displayed range of -20.00 D to +20.00 D and a dynamic range from -5.00 D to +16.00 D.

Clarity said that that availability of real-time refractive feedback may also be of benefit in complicated cases, such as highly aberrated corneas with unusual anterior and posterior corneal power distributions; irregular astigmatism; and prior refractive surgery.

In such situations, standard IOL power calculations may provide less-than-desired results.

Clarity, which holds several patents in real-time intraoperative wavefront aberrometry, said it is already planning upgrades to the HOLOS IntraOp platform.

The current software capabilities offer ability to manage a full range of cataract cases, including pseudophakic IOL power confirmation for standard, multifocal, and toric IOLs. In 2016, Clarity will release software to accurately predict the required IOL power using an aphakic measurement.

Clarity's HOLOS IntraOp, is a continuous real-time intraoperative aberrometer for refractive cataract surgery.

((Comments on this story may be sent to

COPYRIGHT 2015 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Nov 16, 2015
Previous Article:US FDA Advises Medical Device Maker AirXpanders to Use "de novo" Process for AeroForm.
Next Article:With FDA Clearance, Minimally Invasive Prostate Cancer Treatment Now Available in US.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters